RE

Renalytix plc

  • CIK: 0001811115
  • EIN: 00-0000000
  • Business address: FINSGATE, 5-7 CRANWOOD STREET, LONDON, United Kingdom, EC1V 9EE

Information

  • Mailing address
    FINSGATE, 5-7 CRANWOOD STREET, LONDON, Delaware, EC1V 9EE
  • Phone
    44 29 2071 0570
  • State location
    United Kingdom
  • State of incorporation
    Delaware
  • Fiscal year end
    June 30
  • SIC
    8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
  • Filings
    N/A

About Renalytix plc

Renalytix plc (CIK: 0001811115) is an American company incorporated in the state of United Kingdom. Head office is located at FINSGATE, 5-7 CRANWOOD STREET, LONDON, United Kingdom, EC1V 9EE. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. Renalytix plc is a public company and trade via Over-The-Counter (OTC).

Old names:

  • Renalytix AI plc from 2020-15-May to 2021-25-Jun

Ownership

Owner Filings Transaction Date Type of Owner
Doran Howard JR 0001415965 Sep-01-2023 officer: Chief Business Officer
LEVANGIE DANIEL J 0001187406 Jul-01-2023 director
MCLAIN THOMAS H 0001206465 Jul-01-2023 officer: President
MILLS CHRISTOPHER 0001223129 Jul-01-2023 director, 10 percent owner
Scannell Timothy J 0001451533 Jul-01-2023 director
Coste Catherine 0001821432 Jul-01-2023 director
Sterling O. James 0001851144 Jul-01-2023 officer: Chief Financial Officer
MOUNT SINAI HEALTH SYSTEM, INC. 0001883135 Jul-01-2023 10 percent owner
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 0001883139 Jul-01-2023 10 percent owner
MOUNT SINAI HOSPITALS GROUP, INC. 0001885494 Jul-01-2023 10 percent owner
MOUNT SINAI HOSPITAL 0001899689 Jul-01-2023 10 percent owner
Fleming Fergus 0001973429 Jul-01-2023 director, officer: Chief Technical Officer
Parikh Chirag R. 0001973565 Jul-01-2023 director
Lium Erik 0001973569 Jul-01-2023 director
McCullough James Renwick 0001974146 Jul-01-2023 director, officer: Chief Executive Officer
Donovan Michael J. 0001975278 Jul-01-2023 officer: Chief Medical Officer

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Renalytix plc

Filings Format Description Filed/Effective File/Film Number
SCHEDULE 13G Document Acc-no: 0001610520-25-000008 (34 Act) Size: KB Feb-10-2025

005-93440

25603949
8-K Document

Current report filing

Acc-no: 0001213900-25-004220 (34 Act) Size: KB		 Jan-16-2025

001-39387

25535991
8-K Document

Current report filing

Acc-no: 0001213900-24-111219 (34 Act) Size: KB		 Dec-20-2024

001-39387

241568406
DEF 14A Document

Definitive proxy statements

Acc-no: 0001213900-24-102087 (34 Act) Size: KB		 Nov-25-2024

001-39387

241495648
8-K/A Document

Amendment to Current report filing

Acc-no: 0001213900-24-100211 (34 Act) Size: KB		 Nov-19-2024

001-39387

241477048
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000950170-24-128687 (34 Act) Size: KB		 Nov-19-2024

001-39387

241476735
NT 10-Q Document

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Acc-no: 0001213900-24-098540 (34 Act) Size: KB		 Nov-14-2024

001-39387

241463942
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001104659-24-118635 (34 Act) Size: KB		 Nov-14-2024

005-93440

241459300
PRE 14A Document

Preliminary proxy statement not related to a contested matter or merger/acquisition

Acc-no: 0001213900-24-096777 (34 Act) Size: KB		 Nov-12-2024

001-39387

241449431
SC 13D/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0001104659-24-115272 (34 Act) Size: KB		 Nov-07-2024

005-93440

241435219
8-K Document

Current report filing

Acc-no: 0001213900-24-095002 (34 Act) Size: KB		 Nov-06-2024

001-39387

241431347
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000950170-24-121609 ( Act) Size: 0 KB		 Nov-05-2024

SC 13D/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0001341004-24-000185 (34 Act) Size: KB		 Nov-05-2024

005-93440

241428383
DEF 14A Document

Definitive proxy statements

Acc-no: 0001193125-24-236760 (34 Act) Size: KB		 Oct-11-2024

001-39387

241367950
25 Document

Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange

Acc-no: 0001193125-24-233820 (34 Act) Size: 0 KB		 Oct-07-2024

001-39387

241358161
SC 13D/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0001104659-24-105554 (34 Act) Size: KB		 Oct-02-2024

005-93440

241349554
PRE 14A Document

Preliminary proxy statement not related to a contested matter or merger/acquisition

Acc-no: 0001193125-24-230327 (34 Act) Size: KB		 Oct-01-2024

001-39387

241344364
8-K Document

Current report filing

Acc-no: 0001193125-24-230319 (34 Act) Size: KB		 Oct-01-2024

001-39387

241344337
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0000950170-24-110315 (34 Act) Size: KB		 Sep-30-2024

001-39387

241339136
8-K Document

Current report filing

Acc-no: 0000950170-24-100790 (34 Act) Size: KB		 Aug-27-2024

001-39387

241243172

Recent 20 filings. View all Renalytix plc filings

Reviews

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • Renalytix plc overview
  • Renalytix plc job
  • Renalytix plc stock
  • Renalytix plc ownership
  • Renalytix plc CEO
  • Renalytix plc documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

GenEmbryomics Ltd
Update: Feb 21, 2025
Advanced Biomed Inc.
Update: May 23, 2023
Fortrea Holdings Inc.
Update: May 16, 2023
LUDWIG ENTERPRISES, INC.
Update: Apr 26, 2023
WORKPLACE COMPLIANCE INC
Update: Aug 25, 2022
WEAVIL DAVID C
Update: Aug 25, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2653 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 4903 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1386 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 4277 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1220 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 4169 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4390 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3261 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4411 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by